We searched PUBMED and EMBASE databases for studies conducted from 1966 through January 2012. Data were independently abstracted by 2 investigators using a standardized protocol. Study-specific risk estimates were combined by using a random-effects model.
A total of nine general population cohorts with 216,908 participants and more than 5249 CHD cases were included in the meta-analysis. The summary relative risk (RR) did not indicate a significant association between the highest flavonols intake and reduced risk of CHD (summary RR: 0.91; 95%CI: 0.83, 1.01). Furthermore, no significant association was found through the dose-response analysis (an increment of 20 mg/day, summary RR: 0.96; 95%CI: 0.90, 1.03).
Our results do not support a protective role of flavonols intake against CHD.